Edible vaccines are biological preparations produced in transgenic plants that stimulate immunity against various diseases, including infectious and autoimmune diseases. They offer advantages such as ease of administration, cost-effectiveness, and the ability to provide systemic and mucosal immunity, but face limitations and regulatory challenges. Current research highlights candidates like potatoes, bananas, and tomatoes for vaccine development, with successful trials noted for diseases such as Norwalk virus and hepatitis B.
Related topics: